Evaluation of blood biomarkers for the diagnosis of leprosy and the monitoring of treatment efficacy: IGRA and HBHA (HILE)

This is a pilot study whose main aim is to transpose the principle of the IGRA test for M. leprae and to assess whether the combination of HBHA and ESAT-6/CFP-10 can help to distinguish the latent forms of leprosy from the active forms and to establish infection clearance.